Lyterian Therapeutics focuses on developing novel medicines for patients by leveraging protein homeostatic mechanisms to target genetically validated proteins. The company employs a multidisciplinary approach that combines cell biology, structural biology, biophysics, and medicinal chemistry to advance drug discovery efforts, particularly in the realm of protein degradation. Lyterian is committed to fostering a diverse and inclusive workplace, recognizing that a collaborative environment is essential to scientific innovation and success. The team at Lyterian seeks individuals who are proactive, self-motivated, and passionate about exploring fundamental biology and therapeutic strategies, offering a dynamic culture for those aspiring to make a significant impact in the biopharmaceutical field.